Nigamnarayan (Nigam) Acharya is a shareholder in Baker Donelson's Atlanta office. His practice includes both litigation and client counseling in the fields of patent, trademark and unfair competition law, and he has particular experience in patent disputes and prosecution, Hatch-Waxman matters and large-scale trademark registration and enforcement projects, including Trademark Trial and Appeal Board matters.

Mr. Acharya has helped companies use intellectual property portfolios to enhance equity investments and has litigated and counseled on Hatch-Waxman matters, including work in relation to Abbreviated New Drug Applications (ANDAs) on compounds such as bendamustine (Treanda®), sertraline (Zoloft®) and ciprofloxacin (Cipro®). He regularly analyzes the patent landscape relating to new product proposals and works closely with scientists at an early stage to advise on design-around strategies for ANDA filings.

Mr. Acharya also has scientific research experience. As an undergraduate student, his experience included work in biophysical chemistry, in which he studied the thermodynamic parameters of protein-nucleic acid interactions. He gained experience with techniques such as microcalorimetry, fluorescence and nuclear magnetic resonance. In graduate school, Mr. Acharya's research experience included work on organic synthesis chemistry involving novel flavonoids.

Mr. Acharya is also active in the Indian community, serving in various organizations that foster business relationships between the U.S. and India.